Related Experiment Video
Updated: Oct 26, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Paediatric mitral valve disease - from presentation to management
Sashini Iddawela1, Prince Josiah Sajanthan Joseph2, Roshan Ganeshan3
1Department of Cardiology, University Hospitals Birmingham, Birmingham, UK. sashini.iddawela@nhs.net.
Insights
Paediatric mitral valve disease, though rare, poses significant risks. Emerging percutaneous interventions offer new treatment avenues, potentially improving outcomes alongside traditional surgical methods.
Area of Science:
- Cardiology
- Paediatric Cardiovascular Medicine
- Valvular Heart Disease
Background:
- Mitral valve diseases in children are uncommon but lead to significant mortality and morbidity.
- Acquired causes are a primary contributor to paediatric cardiovascular disease burden.
- Diagnosis can occur prenatally, at birth, or later with heart failure symptoms.
Purpose of the Study:
- To review current understanding and emerging trends in paediatric mitral valve disease management.
- To highlight the evolving role of surgical and percutaneous interventions.
- To emphasize the need for further research on intervention outcomes and quality of life.
Main Methods:
- Review of existing literature on paediatric mitral valve disease epidemiology.
- Analysis of current treatment modalities including surgical repair and replacement.
- Evaluation of emerging percutaneous mitral valve interventions.
Main Results:
- Rheumatic disease and congenital defects are predominant causes of paediatric mitral valve disease.
- Mitral valve repair and replacement remain standard treatments, with repair gaining popularity.
- Percutaneous mitral valve interventions are emerging as potential bridge-to-surgery options or definitive treatments for high-risk patients.
Conclusions:
- Mitral valve repair is increasingly favored, but its long-term outcomes need more study.
- Percutaneous mitral balloon valvuloplasty shows promise as a treatment adjunct.
- The impact of interventions on paediatric patients' quality of life warrants further investigation.
Abstract:
Mitral valve diseases are relatively rare in the paediatric population; however, they can cause considerable mortality and morbidity worldwide. Acquired causes are a major contributor to cardiovascular disease burden in the paediatric population. Diseases can be detected before birth, at birth, or when the child is older and presents with symptoms of advanced heart failure. Definitive management consists of surgical intervention, with mitral valve replacement being the gold standard.Conclusion: Repair has been gaining popularity; however, its outcomes require further study. Percutaneous mitral balloon valvuloplasty is an emerging technique which holds promise as a bridge to surgical treatment. The effect of these interventions on quality of life must be emphasised and requires further study. What is Known: • The epidemiology of mitral valve disease in the paediatric population - predominant causes include rheumatic disease and congenital defects. • Mitral valve repair and replacement are the standard treatment methods for paediatric mitral valve disease. What is New: • Emergence of percutaneous mitral valve interventions and their potential as bridge-to-surgery or definitive treatment in high-risk surgical candidates. • Recent evidence comparing mitral valve repair and replacement in the paediatric population demonstrates increasing popularity of repair techniques.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

